Impact of the 21-gene Recurrence Score assay on the treatment of estrogen receptor-positive, HER2-negative, breast cancer patients with 1-3 positive nodes: A prospective clinical utility study
2015 ◽
Vol 38
(1-2)
◽
pp. 24-27
◽
2017 ◽
2014 ◽
Vol 8
(8)
◽
pp. 1679-1689
◽
2015 ◽
Vol 22
(6)
◽
pp. 2034-2039
◽